The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience

BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transfusion (Philadelphia, Pa.) Pa.), 2009-03, Vol.49 (3), p.421-426
Hauptverfasser: Quillen, Karen, Yau, Yu Ying, Leitman, Susan F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 426
container_issue 3
container_start_page 421
container_title Transfusion (Philadelphia, Pa.)
container_volume 49
creator Quillen, Karen
Yau, Yu Ying
Leitman, Susan F.
description BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L). RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L). CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.
doi_str_mv 10.1111/j.1537-2995.2008.01997.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20407727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEoqXwCsgXuGWx4ySOOSChlhZEBYgu4mg5zmTXi2Nvbafd5R15J7x_tG1P4IttzTe_GXu-LEMET0habxYTUlGWF5xXkwLjZoIJ52yyepQdHwKPs2OMS5ITQouj7FkIC4xxwTF5mh0RjktccXac_ZnOAXUQwQ_aShsDcj2aeWlH49Q6AlprMB3SFhHCmwcR5awCG72MENLFGFAROtR7N6DRejByc71xZrQRwKPOWecDGlyrjf6dQrc6zlPtlRwgzmVwFpC03f0aecI6u85D1MOYeNrOUC9VdP4tkojQfA3SI1gtwWtI3TzPnvTSBHix30-yH-cfpqcf88uvF59O31_mqmIFy_um5qyWXVMVlNcSy56BIlTWLQeKW1LVHHrKStbitmwolQ2QWuGu6hpakQbTk-zdjrsc2wG63TcYsfR6kH4tnNTiYcTquZi5G0HLguCCJcDrPcC76xFCFIMOCoyRFtwYRF3zmjFc_lNYpEEytiU2O6HyLgQP_aEbgsXGNGIhNt4QG2-IjWnE1jRilVJf3n_NXeLeJUnwai-QQUnTpwEpHQ66ghS4oqS5-5ZbbWD93w2I6ffz7TEB8h1AhwirA0D6X6JmlFXi55cLcfbt7HNzNb0SnP4FqYrzlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20407727</pqid></control><display><type>article</type><title>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Quillen, Karen ; Yau, Yu Ying ; Leitman, Susan F.</creator><creatorcontrib>Quillen, Karen ; Yau, Yu Ying ; Leitman, Susan F.</creatorcontrib><description>BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L). RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L). CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/j.1537-2995.2008.01997.x</identifier><identifier>PMID: 19040597</identifier><identifier>CODEN: TRANAT</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adult ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Donors ; Blood Platelets - cytology ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Cell Separation - methods ; Dexamethasone - pharmacology ; Female ; Granulocyte Colony-Stimulating Factor - pharmacology ; Granulocytes - cytology ; Granulocytes - drug effects ; Humans ; Leukocyte Count ; Male ; Medical sciences ; Middle Aged ; Time Factors ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Transfusion (Philadelphia, Pa.), 2009-03, Vol.49 (3), p.421-426</ispartof><rights>2009 American Association of Blood Banks</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</citedby><cites>FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1537-2995.2008.01997.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1537-2995.2008.01997.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21205318$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19040597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quillen, Karen</creatorcontrib><creatorcontrib>Yau, Yu Ying</creatorcontrib><creatorcontrib>Leitman, Susan F.</creatorcontrib><title>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L). RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L). CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.</description><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Donors</subject><subject>Blood Platelets - cytology</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Cell Separation - methods</subject><subject>Dexamethasone - pharmacology</subject><subject>Female</subject><subject>Granulocyte Colony-Stimulating Factor - pharmacology</subject><subject>Granulocytes - cytology</subject><subject>Granulocytes - drug effects</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Time Factors</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks9u1DAQxiMEoqXwCsgXuGWx4ySOOSChlhZEBYgu4mg5zmTXi2Nvbafd5R15J7x_tG1P4IttzTe_GXu-LEMET0habxYTUlGWF5xXkwLjZoIJ52yyepQdHwKPs2OMS5ITQouj7FkIC4xxwTF5mh0RjktccXac_ZnOAXUQwQ_aShsDcj2aeWlH49Q6AlprMB3SFhHCmwcR5awCG72MENLFGFAROtR7N6DRejByc71xZrQRwKPOWecDGlyrjf6dQrc6zlPtlRwgzmVwFpC03f0aecI6u85D1MOYeNrOUC9VdP4tkojQfA3SI1gtwWtI3TzPnvTSBHix30-yH-cfpqcf88uvF59O31_mqmIFy_um5qyWXVMVlNcSy56BIlTWLQeKW1LVHHrKStbitmwolQ2QWuGu6hpakQbTk-zdjrsc2wG63TcYsfR6kH4tnNTiYcTquZi5G0HLguCCJcDrPcC76xFCFIMOCoyRFtwYRF3zmjFc_lNYpEEytiU2O6HyLgQP_aEbgsXGNGIhNt4QG2-IjWnE1jRilVJf3n_NXeLeJUnwai-QQUnTpwEpHQ66ghS4oqS5-5ZbbWD93w2I6ffz7TEB8h1AhwirA0D6X6JmlFXi55cLcfbt7HNzNb0SnP4FqYrzlA</recordid><startdate>200903</startdate><enddate>200903</enddate><creator>Quillen, Karen</creator><creator>Yau, Yu Ying</creator><creator>Leitman, Susan F.</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200903</creationdate><title>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</title><author>Quillen, Karen ; Yau, Yu Ying ; Leitman, Susan F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Donors</topic><topic>Blood Platelets - cytology</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Cell Separation - methods</topic><topic>Dexamethasone - pharmacology</topic><topic>Female</topic><topic>Granulocyte Colony-Stimulating Factor - pharmacology</topic><topic>Granulocytes - cytology</topic><topic>Granulocytes - drug effects</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Time Factors</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quillen, Karen</creatorcontrib><creatorcontrib>Yau, Yu Ying</creatorcontrib><creatorcontrib>Leitman, Susan F.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quillen, Karen</au><au>Yau, Yu Ying</au><au>Leitman, Susan F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2009-03</date><risdate>2009</risdate><volume>49</volume><issue>3</issue><spage>421</spage><epage>426</epage><pages>421-426</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><coden>TRANAT</coden><abstract>BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L). RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L). CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19040597</pmid><doi>10.1111/j.1537-2995.2008.01997.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1132
ispartof Transfusion (Philadelphia, Pa.), 2009-03, Vol.49 (3), p.421-426
issn 0041-1132
1537-2995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421027
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Blood Donors
Blood Platelets - cytology
Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis
Bone marrow, stem cells transplantation. Graft versus host reaction
Cell Separation - methods
Dexamethasone - pharmacology
Female
Granulocyte Colony-Stimulating Factor - pharmacology
Granulocytes - cytology
Granulocytes - drug effects
Humans
Leukocyte Count
Male
Medical sciences
Middle Aged
Time Factors
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
title The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T05%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20determinants%20of%20granulocyte%20yield%20in%201198%20granulocyte%20concentrates%20collected%20from%20unrelated%20volunteer%20donors%20mobilized%20with%20dexamethasone%20and%20granulocyte-colony-stimulating%20factor:%20a%2013-year%20experience&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Quillen,%20Karen&rft.date=2009-03&rft.volume=49&rft.issue=3&rft.spage=421&rft.epage=426&rft.pages=421-426&rft.issn=0041-1132&rft.eissn=1537-2995&rft.coden=TRANAT&rft_id=info:doi/10.1111/j.1537-2995.2008.01997.x&rft_dat=%3Cproquest_pubme%3E20407727%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20407727&rft_id=info:pmid/19040597&rfr_iscdi=true